BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 12721929)

  • 1. Ensuring injection safety during measles immunization campaigns: more than auto-disable syringes and safety boxes.
    Hersh BS; Carr RM; Fitzner J; Goodman TS; Mayers GF; Everts H; Laurent E; Larsen GA; Bilous JB
    J Infect Dis; 2003 May; 187 Suppl 1():S299-306. PubMed ID: 12721929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measles supplementary immunization activities and GAVI funds as catalysts for improving injection safety in Africa.
    Hoekstra EJ; van den Ent MM; Dao H; Khalaf H; Salovaara A
    J Infect Dis; 2011 Jul; 204 Suppl 1():S190-7. PubMed ID: 21666161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring vaccine safety during measles mass immunization campaigns: clinical and programmatic issues.
    Pless RP; Bentsi-Enchill AD; Duclos P
    J Infect Dis; 2003 May; 187 Suppl 1():S291-8. PubMed ID: 12721928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hidden reality on the introduction of auto-disable syringes in developing countries.
    Kuroiwa C; Suzuki A; Yamaji Y; Miyoshi M
    Southeast Asian J Trop Med Public Health; 2004 Dec; 35(4):1019-23. PubMed ID: 15916108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reducing the risk of unsafe injections in immunization programmes: financial and operational implications of various injection technologies.
    Aylward B; Lloyd J; Zaffran M; McNair-Scott R; Evans P
    Bull World Health Organ; 1995; 73(4):531-40. PubMed ID: 7554027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Auto-disable syringes for immunization: issues in technology transfer.
    Lloyd JS; Milstien JB
    Bull World Health Organ; 1999; 77(12):1001-7. PubMed ID: 10680248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of immunization injections in Africa: not simply a problem of logistics.
    Dicko M; Oni AQ; Ganivet S; Kone S; Pierre L; Jacquet B
    Bull World Health Organ; 2000; 78(2):163-9. PubMed ID: 10743280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Injection practices in southern part of India.
    Rajasekaran M; Sivagnanam G; Thirumalaikolundusubramainan P; Namasivayam K; Ravindranath C
    Public Health; 2003 May; 117(3):208-13. PubMed ID: 12825472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Injection safety: knowledge and practice among health workers.
    Ernest SK
    West Afr J Med; 2002; 21(1):70-3. PubMed ID: 12081351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The challenge of achieving measles elimination in the eastern Mediterranean region by 2010.
    Gaafar T; Moshni E; Lievano F
    J Infect Dis; 2003 May; 187 Suppl 1():S164-71. PubMed ID: 12721909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measles eradication in the Americas: experience in Haiti.
    Venczel L; Dobbins J; André J; Laender F; Izurieta H; Delorme P; Voltaire HC
    J Infect Dis; 2003 May; 187 Suppl 1():S127-32. PubMed ID: 12721903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safe and newer injection technologies.
    Sharma S
    J Indian Med Assoc; 2005 Apr; 103(4):215-6, 218, 221. PubMed ID: 16173428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety, effectiveness and ease of use of a non-reusable syringe in a developing country immunization programme.
    Steinglass R; Boyd D; Grabowsky M; Laghari AG; Khan MA; Qavi A; Evans P
    Bull World Health Organ; 1995; 73(1):57-63. PubMed ID: 7704926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Injection safety for immunisation--Andhra Pradesh experience.
    Kaipilyawar SB; Rao RG
    J Indian Med Assoc; 2005 Apr; 103(4):222-5. PubMed ID: 16173430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved injection safety after targeted interventions in the Syrian Arab Republic.
    Mantel C; Khamassi S; Baradei K; Nasri H; Mohsni E; Duclos P
    Trop Med Int Health; 2007 Mar; 12(3):422-30. PubMed ID: 17313514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sterilizable syringes: excessive risk or cost-effective option?
    Battersby A; Feilden R; Nelson C
    Bull World Health Organ; 1999; 77(10):812-9. PubMed ID: 10593029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress toward measles eradication in the region of the Americas.
    De Quadros CA; Izurieta H; Carrasco P; Brana M; Tambini G
    J Infect Dis; 2003 May; 187 Suppl 1():S102-10. PubMed ID: 12721900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress in global measles control and mortality reduction, 2000-2007.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Dec; 57(48):1303-6. PubMed ID: 19052529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of SoloShot autodestruct syringes compared with disposable syringes, in a national immunization campaign in Indonesia.
    Nelson CM; Sutanto A; Suradana IG
    Bull World Health Organ; 1999; 77(1):29-33. PubMed ID: 10063658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid assessment of injection practices in Cambodia, 2002.
    Vong S; Perz JF; Sok S; Som S; Goldstein S; Hutin Y; Tulloch J
    BMC Public Health; 2005 Jun; 5():56. PubMed ID: 15929800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.